2Hansson L,Zanchetti A,Carruthers SG,et al.Effects with hypertension:principal results of the hypertension Optimal Treatment(HOT)randomised trial[].The Lancet.1998 被引量：1
3Julius S,Kjeldsen SE,Weber.Outcomes in hypertension patients at high cardiovascular risk treated with regimens besed on valsartan or amlodipine:the VALUE randomised trial[].The Lancet.2004 被引量：1
4Gu D,Reynold K,Wu X,et al.Prevalence,awareness,treatment,and control of hypertension in China[].Journal of Hypertension.2002 被引量：1
6Wright JM,Lee CH,Chambers GK.Systematic review of antihypertensive therapies:Does the evidence assist in choosing a first-line drug[].Canadian Medical Association Journal.1999 被引量：1
7Kjeldsen SE,Westheim A,Os I.INSIGHT and NORDIL.International Nifedipine GITS study:Intervention as a Goal in Hypertension Treatment.Nordic Diltiazem Study[].The Lancet.2000 被引量：1
8Weir MR,Dzau VJ.The renin-angiotensin-aldos terone system:a specific target for hypertension management[].American Journal of Hypertension.1999 被引量：1
9Gansevoort RT,Sluiter WJ,Hemmelder MH,et al.Antiproteinuric effect of blood-pressure-lowering agents:a meta-analysis of comparative trials[].Nephrology Dialysis Transplantation.1995 被引量：1
